CIK 0001385818 · Non-accelerated filer<br>Smaller reporting company
AYTU BIOPHARMA, INC
Sign in to watch- Ticker
- AYTU
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Jun 30
- Incorporated
- DE
- Entity type
- operating
- EIN
- 470883144
- Phone
- (720) 437-6580
- Business address
- 7900 E. UNION AVENUE, SUITE 920, DENVER, CO, 80237
- Former names
- AYTU BIOSCIENCE, INC, Rosewind CORP
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-06-09 | Disbrow Joshua R. Chief Executive Officer | Purchase | +66,666 | $1.50 | $100K | 153,257 |
| 2025-06-06 | Nantahala Capital Management, LLC 10% owner | Purchase · Prefunded Warrants | +4,000,000 | $1.50 | $6.0M | 4,815,217 |
| 2025-03-31 | PYSZCZYMUKA GREG Chief Commercial Officer | Option exercise | +209 | 23,602 | ||
| 2025-03-31 | PYSZCZYMUKA GREG Chief Commercial Officer | Option exercise · Restricted Stock Units | −209 | 0 | ||
| 2025-02-28 | Disbrow Joshua R. Chief Executive Officer | Purchase | +15,000 | $1.30 | $20K | 86,591 |
| 2025-02-05 | Selhorn Ryan J Chief Financial Officer | Option exercise | +105 | 16,000 | ||
| 2025-02-05 | Selhorn Ryan J Chief Financial Officer | Option exercise · Restricted Stock Units | −105 | 0 | ||
| 2024-12-31 | PYSZCZYMUKA GREG Chief Commercial Officer | Option exercise | +208 | 23,393 | ||
| 2024-12-31 | PYSZCZYMUKA GREG Chief Commercial Officer | Option exercise · Restricted Stock Units | −208 | 209 | ||
| 2024-11-11 | Selhorn Ryan J Chief Financial Officer | Grant or award | +14,000 | 15,895 | ||
| 2024-11-06 | DOCKERY CARL Director | Grant or award | +1,500 | 10,440 | ||
| 2024-11-06 | Donofrio John Jr. Director | Grant or award | +1,500 | 3,762 | ||
| 2024-11-06 | JAIN ABHINAV Director | Grant or award | +1,500 | 9,500 | ||
| 2024-11-06 | Disbrow Joshua R. Chief Executive Officer | Grant or award · Employee Stock Option (Right to Buy) | +38,000 | 38,000 | ||
| 2024-11-06 | Disbrow Jarrett Chief Business Officer | Grant or award · Employee Stock Option (Right to Buy) | +7,000 | 7,000 | ||
| 2024-11-06 | LIU VIVIAN H Director | Grant or award | +1,500 | 9,825 | ||
| 2024-11-06 | PYSZCZYMUKA GREG Chief Commercial Officer | Grant or award · Employee Stock Option (Right to Buy) | +7,000 | 7,000 | ||
| 2024-09-30 | PYSZCZYMUKA GREG Chief Commercial Officer | Option exercise | +209 | 23,185 | ||
| 2024-09-30 | PYSZCZYMUKA GREG Chief Commercial Officer | Option exercise · Restricted Stock Units | −209 | 417 | ||
| 2024-06-30 | PYSZCZYMUKA GREG Chief Commercial Officer | Option exercise | +208 | 22,976 |
Page 2 of 15 · 300 trades